Rigel Pharmaceuticals, Inc.
RIGL
$18.29
-$0.32-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 77.10M | 77.32M | 61.11M | 49.10M | 49.55M |
| Total Receivables | 41.55M | 41.62M | 30.58M | 28.90M | 27.51M |
| Inventory | 16.39M | 9.80M | 8.18M | 10.26M | 7.28M |
| Prepaid Expenses | 5.15M | 6.37M | 6.59M | 6.46M | 8.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.38M | -- | -- | -- | -- |
| Total Current Assets | 146.56M | 135.10M | 106.47M | 94.72M | 92.49M |
|
|
|||||
| Total Current Assets | 146.56M | 135.10M | 106.47M | 94.72M | 92.49M |
| Net Property, Plant & Equipment | 1.38M | 338.00K | 504.00K | 675.00K | 852.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 26.51M | 27.10M | 27.69M | 28.28M | 28.86M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.52M | 1.44M | 4.76M | 4.74M | 4.32M |
| Total Assets | 175.97M | 163.98M | 139.42M | 128.41M | 126.52M |
|
|
|||||
| Total Accounts Payable | 3.95M | 3.34M | 3.82M | 6.13M | 9.28M |
| Total Accrued Expenses | 41.55M | 46.33M | 43.68M | 31.15M | 26.74M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.27M | 7.56M | 466.00K | 639.00K | 16.49M |
| Total Finance Division Other Current Liabilities | 5.85M | 6.08M | 6.36M | 20.73M | 20.69M |
| Total Other Current Liabilities | 5.85M | 6.08M | 6.36M | 20.73M | 20.69M |
| Total Current Liabilities | 66.63M | 63.30M | 54.31M | 58.65M | 73.20M |
|
|
|||||
| Total Current Liabilities | 66.63M | 63.30M | 54.31M | 58.65M | 73.20M |
| Long-Term Debt | 84.91M | 92.39M | 99.74M | 99.67M | 84.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 864.00K | -- | -- | -- | 100.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.00M | 5.00M | -- | -- | -- |
| Total Liabilities | 157.41M | 160.69M | 154.06M | 158.32M | 158.19M |
|
|
|||||
| Common Stock & APIC | 1.40B | 1.39B | 1.39B | 1.39B | 1.38B |
| Retained Earnings | -1.38B | -1.39B | -1.40B | -1.42B | -1.42B |
| Treasury Stock & Other | -2.00K | 10.00K | 11.00K | -9.00K | -5.00K |
| Total Common Equity | 18.57M | 3.29M | -14.64M | -29.91M | -31.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.57M | 3.29M | -14.64M | -29.91M | -31.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.57M | 3.29M | -14.64M | -29.91M | -31.67M |
|
|
|||||